TY - JOUR T1 - Conservative management of COVID-19 associated hypoxaemia JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00113-2021 VL - 7 IS - 2 SP - 00113-2021 AU - Wolfram Windisch AU - Stefan Kluge AU - Martin Bachmann AU - Carl-Peter Criée AU - Steffen Weber-Carstens AU - Michael Westhoff AU - Christian Karagiannidis AU - Tobias Welte Y1 - 2021/04/01 UR - http://openres.ersjournals.com/content/7/2/00113-2021.abstract N2 - With appropriate esteem, we have read the article by Voshaar et al. [1] on the management of hypoxaemia related to COVID-19 pneumonia. The authors have concluded that treatment escalation in the sequence 1) supplemental oxygen; 2) nasal high-flow, continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV); and 3) invasive mechanical ventilation resulted in low overall mortality if guided by the calculation of oxygen content in addition to the clinical presentation. We fully agree with the authors and others [2, 3] that hypoxaemia per se should not serve as the exclusive indication parameter for intubation. However, we disagree that this statement is, in any manner, supported by the data presented by Voshaar et al. [1].This correspondence argues that the conclusion given in the article “Conservative management of COVID-19-associated hypoxaemia” is not supported by the data https://bit.ly/3qAn7la ER -